We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics
News

RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics

RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics
News

RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

RainDance Technologies, Inc. has filed a patent infringement suit against 10X Genomics, Inc. (“10X”) of Pleasanton, California. The suit was filed in Federal District Court in Delaware. The patents asserted are U.S. patent numbers 7129091, 822148, 8273573, 8304193, 8329407, and 889083, which are all exclusively licensed to RainDance from the University of Chicago. 10X has recently begun to offer for sale a system that infringes RainDance’s patent rights, and RainDance filed this suit to vigorously defend its intellectual property and current and future products.

Complex Genetics Made Simple

RainDance Technologies offers a full product portfolio to research cell-free and cell-based biomarkers for hereditary risk predisposition, initial detection, pathology, and residual disease. The company’s research-use products include:

  • RainDrop® Digital PCR System: Ultra-sensitive digital PCR system for research of early detection and monitoring of cell-free and cell-based biomarkers for cancers, viruses, pathogens, and immune disorders.
  • ThunderBolts™ Cancer Panels: ‘Democratized’ targeted Next-Generation Sequencing (NGS) panels enabling highly sensitive, rapid, low input, tumor profiling research in plasma, tissue and FFPE samples.
  • ThunderStorm® NGS Content Enrichment System: Industrial-scale workhorse for highly accurate, fully automated targeted NGS enrichment.

Advertisement